ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 517,68
1,22%
Dow Jones
40 589,34
1,64%
DAX
18 417,55
0,62%
Brent Oil
79,745
0,00%
Bitcoin
67 875,77
-0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) Actualités

ABT Abbott Laboratories

100,00
-5,96 (-5,62%)
27 Juil 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Abbott Laboratories ABT NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-5,96 -5,62% 100,00 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
106,78 104,66 107,14 105,24 105,96
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/7/202412:01IHMARKETNEWSMicrosoft Shares Drop 2% and CrowdStrike Plunges 21%..
18/7/202413:37EDGAR2Form 8-K - Current report
18/7/202413:30PRNUSAbbott Reports Second-Quarter 2024 Results and Raises..
18/7/202412:01IHMARKETNEWSNasdaq Tech Stocks Show Partial Recovery; Oil Prices Rise
09/7/202412:54IHMARKETNEWSBP Slashes Profit Forecast by $700 Million; Morgan Stanley..
27/6/202414:00PRNUSAbbott Hosts Conference Call for Second-Quarter Earnings
20/6/202414:05PRNUSAbbott Teams Up With the National Association of Community..
14/6/202418:01PRNUSAbbott Declares 402nd Consecutive Quarterly Dividend
10/6/202414:00PRNUSAbbott Receives U.S. FDA Clearance for Two New..
03/6/202415:00PRNUSCadrenal Therapeutics Highlights Presentation of New Trial..
30/5/202422:07EDGAR2Form SD - Specialized disclosure report
14/5/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:52EDGAR2Form 144 - Report of proposed sale of securities
08/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:59EDGAR2Form 144 - Report of proposed sale of securities
29/4/202415:00PRNUSAbbott's Breakthrough Dissolving Stent Receives FDA Approval..
17/4/202417:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
17/4/202413:30PRNUSAbbott Reports First-Quarter 2024 Results and Raises..
17/4/202412:59IHMARKETNEWSUS Index Futures See Gains, Oil Prices Dip
03/4/202413:12IHMARKETNEWSCal-Maine Surges on Strong Quarterly Performance, Taiwan..
02/4/202415:00PRNUSAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind..
01/4/202415:00PRNUSAbbott Receives FDA Clearance for Whole Blood Rapid Test to..
27/3/202421:30PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
19/3/202413:00PRNCAUne première au Canada -- Abbott fait progresser le..
06/3/202415:00PRNUSReal-World Data Show Abbott's FreeStyle Libre® Systems and..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:45EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:32EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:22EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
ABT
Abbott Laboratories
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés